Diabetic ketoacidosis (DKA) is a build-up of substances called ketones in the blood that can happen if a patient's blood glucose levels are too high for too long and is caused by a lack of insulin ...
The following is a summary of “Identification of Shared Pathways and Molecules Between Type 2 Diabetes and Lung ...
However, people using hybrid closed-loop systems are more likely to experience diabetic ketoacidosis compared to those using open-loop therapies, the study has reported. Type 1 diabetes treatment is ...
Medicine often takes a one-size-fits-all approach, but a disorder's root cause can vary. Vanderbilt researchers have found ...
New therapies for managing aging could emerge from research into a new gene, which scientists have identified as a key driver ...
This study is led by Dr. Haisheng Zhou (Department of Biochemistry and Molecular Biology, Anhui Medical University, China) and Dr. Guoling Zhou (Center for Computational Integrative Biology, ...
2025 — It's well known that consuming sugary drinks increases the risk of diabetes, but the mechanism behind this relationship is unclear. Now researchers show that metabolites produced by gut ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...
Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023. Net product sales of CAPLYTA were $199.2 million for the fourth ...